Sabang, Marissa M.

HRN: 21-41-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2022
CEFUROXIME 1.5GM (VIAL)
05/28/2022
06/04/2022
IVT
1.5g
Q8H
UTI

 Indication:      Type of Infection:      Compliance to guidelines: Non-compliant To Guidelines